CALL US ON
+91 2553 691200
Business Hours: 9.00 am to 5.00 pm
- Products
- Supply Chain Solutions
- Custom Synthesis
- Facilities
- About us
- Investor
- Annual Reports
- Annual Returns
- Disclosures under Regulation 46 of SEBI (LODR) Regulations
- Code of Conduct insider Trading
- Whistle Blower Policy
- Code of fair disclosure
- Corporate Governance
- Corporate Information
- Prospectus
- Grievance Cell
- Shareholding Pattern
- Vigil Machanism
- AGM & Compliances
- Quarterly/Half Yearly Results
- Notices
- Policies
- Encumbrance by Promotors
- Regulation 30
- CSR
-
Product Finder
- OR
Brimonidine Tartrate
Uses:
This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist.
Identifiers
- CAS No:
- [70359-46-5]
- BRN No:
- -
- UN No:
- -
Properties
- Molecular Formula:
- C11H10BrN5
- Molecular Weight:
- 442.22 g/mol
Specifications
| Sr. No. | Test | Limits |
|---|---|---|
| 1 | Description | White or slightly yellowish or slightly brownish powder |
| 2 | Solubility | Soluble in Water, Practically insoluble in anhydrous Ethanol and in Toluene |
| 3 | Identification | |
| a. Specific Optical Rotation | Should comply the test | |
| b. By FTIR | The infrared absorption Spectrum of the sample should be concordant with that of Standard | |
| 4 | Loss on Drying (%, w/w) (At 105°C for 3 hrs) | Not more than 0.5 |
| 5 | Sulphated Ash (%, w/w) | Not more than 0.2 |
| 6 | Specific Optical Rotation (°) [C=1% w/v, in Water at 25°C, On dried substance] | Between +9.00 to +10.5 |
| 7 | Related Substances by HPLC (%, w/w) Unspecified impurities Total impurities | Not more than 0.10 Not more than 0.2 (Disregard limit: 0.05%) |
| 8 | Assay by Potentiometry (%,w/w)
(As |
Not more than 0.2 |
